Navigation Links
Lucintel Profiles Leaders in Generic Drugs Industry: Global Market Expected to Reach US $335.8 Billion in 2017
Date:5/14/2013

Irving, TX (PRWEB) May 14, 2013

Top companies are making strategic acquisitions to expand their global footprint, together with taking advantage of established business and expertise gained through the acquired company. The global generic drugs industry experienced average growth over the last five years and is expected to reach approximately US $335.8 billion in 2017.

Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global generic drugs companies and presents its findings in “Top Five Global Generic Drug Companies Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five generic drug companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.

The fragmented generic drugs industry includes producers of medications whose patent or marketing rights have expired. The industry includes drugs from all therapeutic areas: central nervous system, cardiovascular drugs, oncology drugs, and others. A combination of factors such as technology innovations, patent expiration, aging population, and changing lifestyles substantially affect market dynamics. In this study, Lucintel profiles the following five companies with detailed competitive assessments:

  •     Abbott Laboratories             
  •     Mylan Inc.                                                
  •     Novartis AG                        
  •     Teva Pharmaceuticals Ind. Ltd.    
  •     Watson Pharmaceuticals Inc        

As indicated in Lucintel’s study, the Asia Pacific (APAC) region holds good growth potential. India is expected to play an increasing role in the global economy as demand from a growing population continues to drive consumption for generic drugs. Major pharmaceuticals companies are planning to invest in the Asian markets to gain the market share for generic drugs.

This medical market report provides industry leaders with a competitive benchmarking of the world’s top five generic drug companies. The study provides up-to-date information on the market share, profit margins, capabilities, and business strategies of the leaders. It is designed to provide executives with strategically significant competitor information, data analysis, and insight, critical to the development and implementation of effective marketing and sales plans.

For a detailed table of contents and pricing information on this timely, insightful report, contact Lucintel at +1-972-636-5056 or via email at helpdesk(at)lucintel(dot)com. Lucintel provides cutting-edge decision support services that facilitate critical decisions with greater speed, insight, M & A due diligence and cost efficiency. To learn more, visit http://www.lucintel.com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10730655.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lucintel Estimates Global Home Healthcare Device Industry Reach US $29 Billion in 2017
2. Lucintel Report Outlines $100 Billion Market for Global Oncology Drugs Industry in 2018
3. CodingCertification.Org in the Top 5 Percent in LinkedIn Most Viewed Profiles in 2012
4. Global cardiology leaders meet in Dubai
5. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
6. Leaders in childrens health to gather in Boston
7. Chinese Drywall Complaint Center Now Demands Leadership From Obama & EPA, For Homeowners In Florida And In The US Southeast Stuck In Toxic Chinese Drywall Hell-Forward?
8. UCLA School of Dentistry gets $5M from NIH to train future leaders in oral health research
9. A breath of fresh air: Childhood Asthma Leadership Coalition launches
10. College biology faculty named Leadership Fellows
11. UC Riverside Biologist named a Leadership Fellow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... Cellairis is ... and affordable repairs on iPhone , iPad and Samsung Galaxy devices ... Pearland Walmart in order to maximize convenience and accessibility for customers. While customers ...
(Date:12/9/2016)... ... 09, 2016 , ... Sober College, the game-changing dual diagnosis ... of the Sober College Robert Pfeifer Memorial Learning Center at its location in ... attended by an overwhelming amount of alumni, family, colleagues and friends of Sober ...
(Date:12/9/2016)... ... 09, 2016 , ... MEDI+SIGN®, a provider of fully-automated patient ... solution for Emergency Departments (ED) has been added to their portfolio. Housed in ... rooms, and with a simplified pallet of information available to the patient, the ...
(Date:12/8/2016)... Tampa, FL (PRWEB) , ... December 08, 2016 ... ... been awarded accreditation with distinction by the Undersea and Hyperbaric Medical Society (UHMS), ... patients with advanced care and patient safety. Only a few hospitals and facilities ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... County, a Property owned by an affiliate of Seavest, has won a prestigious ... Medicine Southern Chester County ambulatory care center (ACC) was named “Best New Development, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec. 9, 2016   Hudes Laser Aesthetica ... featuring the multi-wavelength Astanza Trinity laser and Astanza ... in laser tattoo removal, IPL hair removal, pigmented ... therapy. Hudes Laser Aesthetica is setting high standards ... and promises to deliver effective, long-lasting results. ...
(Date:12/9/2016)... , Dec 9, 2016 Research and ... Market - Forecast to 2021" report to their offering. ... ... open innovative models in the pharmaceutical and biotechnology industry and ... rising government funding. Emerging markets and growing research activities in ...
(Date:12/9/2016)... DIEGO , Dec. 9, 2016 aTyr Pharma, Inc. ... discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, ... at the upcoming BMO Prescriptions for Success Healthcare Conference at the ... on Wednesday, December 14, 2016, at 4:20 p.m. ET. ... ...
Breaking Medicine Technology: